FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Graham Juan
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Chung Christine
FibroGen | 10-K: Annual report
FibroGen | 8-K: FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Chung Christine
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Graham Juan
FibroGen | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.93%),Steven Boyd(9.93%)
FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(1.7%),Point72 Asset Management, L.P.(1.6%), etc.
FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.16%)
FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PRIMECAP Management Company(14.72%)
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Wettig Thane
FibroGen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.3%)
FibroGen | 4: Statement of changes in beneficial ownership of securities-CEO Wettig Thane
FibroGen | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Graham Juan
FibroGen | 4: Statement of changes in beneficial ownership of securities-Officer Chung Christine
FibroGen | 4: Statement of changes in beneficial ownership of securities-CEO Wettig Thane
No Data